Dogmas, challenges, and promises in phase III allergen immunotherapy studies

Author:

De Kam Pieter-JanORCID,Kramer Matthias F.ORCID,Shamji Mohamed H.,Oluwayi Kemi,Heath Matthew D.,Jensen-Jarolim Erika,Berger Markus H.,Berger Uwe E.,Graessel AnkeORCID,Sellwood Fiona,Zielen Stefan,Vogelberg Christian,Zieglmayer Petra,Mösges Ralph,Klimek Ludger,DuBuske Lawrence M.,Shreffler Wayne G.,Bernstein Jonathan A.,Kündig Thomas M.,Skinner Murray A.

Publisher

Elsevier BV

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference71 articles.

1. Zur Ursache und spec;Dunbar;Heil.des Heufiebers.Dtsch Med Wochenschr,1903

2. Prophylactic inoculation against hay fever;Noon;Lancet,1911

3. Guideline on the Clinical Development of Products for Specific Immunotherapy for the Treatment of Allergic Diseases. CHMP/EWP/18504/2006. committee for medicinal products for human use (CHMP). https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-development-products-specific-immunotherapy-treatment-allergic-diseases_en.pdf.

4. What we learned from TAO – 10 years of German therapy allergen ordinance;Mahler;Allergo Journal International,2019

5. Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation – summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children, held at Paul-Ehrlich-Institut, Langen, Germany, 16.1.2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3